ORAL MUCOSAL MALIGNANT MELANOMA : CASE REPORT

Yıl 2015, Cilt: 25 Sayı: 1, 85 - 89, 21.05.2015

Selahattin Tuğrul Erol Şentürk Nihat Demirtaş , Pelin Yıldız

https://doi.org/10.17567/dfd.10269

Cited By: 1

Öz

Oral malignant melanoma (OMM) accounts for 0.5% of all oral malignancies which are generally localized in hard and soft plate or gingival tissues in oral cavity. It is suggested that this neoplasms are developing from melanocytes found in the basal layer of the oral mucosa. The malignant melanomas of oral soft tissues are described as oral mucosal malignant melanoma and they should be clearly established in the clinical examination. These lesions are rare but they have aggressive and metastatic character. So, they have an unequivocal bad prognosis. Therefore, the diagnosis may be delayed because of their asymptomatic progression. In this paper, we aimed to present a multidisciplinary treatment method of 52 year-old female patient with oral mucosal melanoma and to emphasize importance of early diagnosis of these lesions

Anahtar Kelimeler

Malignant melanoma, oral mucosa, multidisciplinary treatment

ORAL MUKOZAL MALİGN MELANOMA : OLGU SUNUMU

Öz

Oral bölgede genellikle yumuşak ve sert damak veya dişetlerinde lokalize olan malign melanomalar, tüm oral malignitelerin %0,5’ini oluşturur. Bu neoplazmların oral mukozanın bazal tabakasında bulunan melanositlerden geliştiği düşünülmektedir. Ağız yumuşak dokularında görülen malign melanomalar, oral mukozal malign melanoma olarak tanımlanırlar ve klinik muayenede belirgin olarak gözlemlenebilir. Bu lezyonlar nadir görülmekle birlikte agresif ve metastatik karakterlidir. Bu nedenle prognozları oldukça kötüdür. Ayrıca, asemptomatik seyrettikleri için teşhis edilmeleri gecikmektedir. Bu makalede, 52 yaşındaki bir kadın hastada görülen oral mukozal malign melanoma olgusunun multidisipliner tedavi yaklaşımını sunmak ve bu lezyonların erken teşhisinin önemini vurgulamak amaçlandı.

Anahtar Kelimeler

Malign melanoma, oral mukoza, multidisipliner tedavi

Kaynakça

• Vikey AK, Vikey D. Primary malignant melanoma, of head and neck: A comprehensive review of literature. Oral Oncol 2012; 48:399–403.
• Tanaka N, Mimura M, Ogi K, Amagasa T. Primary malignant melanoma of the oral cavity: Assessment of outcome from the clinical records of 35 patients. Int J Oral Maxillofac Surg 2004; 33:761–5.
• Loree TR, Mullins AP, Spellman J, North JH, Hicks WL. Head and neck mucosal melanoma: a 32-year review. Ear Nose Throat J 1999; 78:372–5.
• Freedman DM, Sigurdson A, Doody MM, Rao RS, Linet MS. Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Cancer Causes Control 2003; 14: 847–57.
• Doval DC, Rao CR, Saitha KS, Vigayakumar M, Misra S, Mani K, Bapsy PP, Kumaraswamy SV. Malignant melanoma of the oral cavity: Report of 14 cases from a regional cancer centre. Eur J Surg Oncol 1996; 22:245–9.
• Hicks MJ, Flaitz CM. Oral mucosal melanoma: Epidemiology and pathobiology. Oral Oncol 2000; 36:152–69.
• Suresh B, Subramanyam RV, Aparna V, Sowjanya P. Intraoral malignant melanoma. Niger Med J 2013; 54:278–81.
• Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27:6199.
• Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Bart RS. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging. Cancer 2000;88:589-95.
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-8.
• Umeda M, Komatsubara H, Shibuya Y, Yokoo S, Komori T. Premalignant melanocytic dysplasia and malignant melanoma of the oral mucosa. Oral Oncol 2002; 38:714-22.
• Rapidis AD, Apostolidis C, Vilos G, Valsamis S. Primary malignant melanoma of the oral mucosa. J Oral Maxillofac Surg 2003; 61:1132–9.
• Bongiorno MR, Aricò M. Primary malignant melanoma of the oral cavity: Case report. Int J Dermatol 2002; 41:178–81.
• Goerres GW, Stoeckli SJ, von Schulthess GK, Steinert HC. FDG PET for mucosal malignant melanoma of the head and neck. Laryngoscope 2002; 112:381–5.
• Kurli M, Reddy S, Tena LB, Pavlick AC, Finger PT. Whole body positron emission tomography/ computed tomography staging of metastatic choroidal 2005;140:193-9. Am J Ophthalmol resection: clinical cases. Acta
• Atallah E, Flaherty L. Treatment of metastatic malignant melanoma. Curr Treat Options Oncol 2005; 6:185-93.
• Onan B, Onan IS, Polat B. Surgical Resection of Solitary Metastasis of Malignant Melanoma to the Right Atrium Tex Heart Inst J 2010; 37: 598–01.
• Barker BF, Carpenter WM, Daniels TE, Kahn MA, Leider AS, Lozada-Nur F, Lynch DP, Melrose R, Merrell P, Morton T, Peters E, Regezi JA, Richards SD, Rick GM, Rohrer MD, Slater L, Stewart JC, Tomich CE, Vickers RA, Wood NK, Young SK. Oral mucosal melanomas: The WESTOP Banff Workshop proceedings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83:672–9.
• Meleti M, Leemans CR, Mooi WJ, van der Waal I. Oral malignant melanoma: The amsterdam experience. J Oral Maxillofac Surg 2007; 65:2181– 6.
• Çakur B, Miloğlu Ö, Horalı A. Radyoterapi ve Kemoterapi Gören Hastalarda Oral Bakım. Atatürk Üniv Diş Hekim Fak Derg 2006; 16: 50-5.
• Agarwal P, Upadhyay R, Agarwal A. Radiotherapy complications and their possible management in the head and neck region. Indian J Dent Res 2012; 23: 843.